Davola, M.E.; Cormier, O.; Vito, A.; El-Sayes, N.; Collins, S.; Salem, O.; Revill, S.; Ask, K.; Wan, Y.; Mossman, K.
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells. Cancers 2023, 15, 1295.
https://doi.org/10.3390/cancers15041295
AMA Style
Davola ME, Cormier O, Vito A, El-Sayes N, Collins S, Salem O, Revill S, Ask K, Wan Y, Mossman K.
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells. Cancers. 2023; 15(4):1295.
https://doi.org/10.3390/cancers15041295
Chicago/Turabian Style
Davola, Maria Eugenia, Olga Cormier, Alyssa Vito, Nader El-Sayes, Susan Collins, Omar Salem, Spencer Revill, Kjetil Ask, Yonghong Wan, and Karen Mossman.
2023. "Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells" Cancers 15, no. 4: 1295.
https://doi.org/10.3390/cancers15041295
APA Style
Davola, M. E., Cormier, O., Vito, A., El-Sayes, N., Collins, S., Salem, O., Revill, S., Ask, K., Wan, Y., & Mossman, K.
(2023). Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells. Cancers, 15(4), 1295.
https://doi.org/10.3390/cancers15041295